Dietary intake profile of patients with schizophrenia

Annals of Clinical Psychiatry

Volumn 18, Issue 2, 2006, Pages 99-105

  Henderson, David C ^a,b   Borba, Christina P ^a   Daley, Tara B ^a   Boxill, Ryan ^a   Nguyen, Dana D ^a   Culhane, Melissa A ^a   Louie, Pearl ^a,b   Cather, Corinne ^a,b   Evins, A Eden ^a,b   Freudenreich, Oliver ^a,b   Taber, Sarah M ^c   Goff, Donald C ^a,b  

^a Freedom Trail Clinic   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Diet; Nutrition; Obesity; Schizophrenia

Indexed keywords

ALCOHOL; ATYPICAL ANTIPSYCHOTIC AGENT; CAFFEINE; CALCIUM; CARBOHYDRATE; CHOLESTEROL; CLOZAPINE; FATTY ACID; FOLIC ACID; OLANZAPINE; PROTEIN; QUETIAPINE; RISPERIDONE; SODIUM; SUCROSE; ZINC; ZIPRASIDONE;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CALORIC INTAKE; CARBOHYDRATE INTAKE; CHOLESTEROL INTAKE; CONTROLLED STUDY; DIETARY INTAKE; ETHNOLOGY; FAT INTAKE; FEMALE; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CENTER; MINERAL INTAKE; NUTRITIONAL ASSESSMENT; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN INTAKE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE; VITAMIN INTAKE;

ADULT; ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; ENERGY INTAKE; FEMALE; FOOD HABITS; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OBESITY; PERIODICITY; PREVALENCE; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; URBAN POPULATION;

EID: 33745102501     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: 10.1080/10401230600614538     Document Type: Article

References (40)

1. Taylor DM, McAskill R: Atypical antipsychotics and weight gain a systematic review. Acta Psychiatr Scand 2000; 101:416-32
2. Allison DB, Mentore JL, Heo M, et al.: Antipsychotic-induced weight gain: A comprehensive research synthesis. Am J Psychiatry 1999; 156:1686-96
3. Brown S, Birtwistle J, Roe L, et al.: The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999; 29:697-701
4. Kawachi I: Physical and psychological consequences of weight gain. J Clin Psychiatry 1999; 60 Suppl 21:5-9
5. Wirshing DA, Spellberg BJ, Erhart SM, et al.: Novel antipsychotics and new onset diabetes. Biol Psychiatry 1998; 44:778-83
6. Allison DB, Fontaine KR, Heo M, et al.: The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry 1999; 60:215-20
7. Homel P, Casey D, Allison DB: Changes in body mass index for individuals with and without schizophrenia, 1987-1996. Schizophr Res 2002; 55:277-84
8. Pi-Sunyer FX: The medical risks of obesity. Obes Surg 2002; 12 Suppl 1:6S-11S
9. Pi-Sunyer FX: Comorbidities of overweight and obesity: Current evidence and research issues. Med Sci Sports Exerc 1999; 31:S602-8
10. Umbricht DS, Pollack S, Kane JM: Clozapine and weight gain. J Clin Psychiatry 1994; 55 Suppl B:157-60
11. Henderson DC, Cagliero E, Gray C, et al.: Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study. Am J Psychiatry 2000; 157:975-81
12. Fontaine KR, Heo M, Harrigan EP, et al.: Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate. Psychiatry Res 2001; 101:277-88
13. McCreadie RG: Diet, smoking and cardiovascular risk in people with schizophrenia: Descriptive study. Br J Psychiatry 2003; 183:534-9
14. Strassnig M, Brar JS, Ganguli R: Nutritional assessment of patients with schizophrenia: A preliminary study. Schizophr Bull 2003; 29:393-7
15. Kriska A, Caspersen C: A collection of physical activity questionnaires for health-related research. J Am Coll Sports Med. 1997; 29:873-78
16. Schakel SF, Sievert YA, Buzzard IM: Sources of data for developing and maintaining a nutrient database. J Am Diet Assoc 1988; 88:1268-71
17. Block G, Hartman AM, Dresser CM, et al.: A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986; 124:453-69
18. NHANES: National Health and Nutrition Examination Survey: 1999-2000 Data Files
19. USDA: United States Department of Agriculture: Food Guide Pyramid (revised 1996). 1992
20. McCreadie R, Macdonald E, Blacklock C, et al.: Dietary intake of schizophrenic patients in Nithsdale, Scotland: Case-control study. BMJ 1998; 317:784-5
21. Lambert TJ, Velakoulis D, Pantelis C: Medical comorbidity in schizophrenia. Med J Aust 2003; 178 Suppl:S67-70
22. Davidson M: Risk of cardiovascular disease and sudden death in schizophrenia. J Clin Psychiatry 2002; 63 Suppl 9:5-11
23. Ryan MC, Thakore JH: Physical consequences of schizophrenia and its treatment: The metabolic syndrome. Life Sci 2002; 71:239-57
24. Kendrick T: Cardiovascular and respiratory risk factors and symptoms among general practice patients with long-term mental illness. Br J Psychiatry 1996; 169:733-9
25. Henderson DC, Cagliero E, Copeland PM, et al.: Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: A frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch Gen Psychiatry 2005; 62:19-28
26. Newcomer JW, Haupt DW, Fucetola R, et al.: Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry 2002; 59:337-45
27. Teegarden D: Calcium intake and reduction in weight or fat mass. J Nutr 2003; 133:2498-2518
28. Ievers-Landis CE, Burant C, Drotar D, et al.: Social support, knowledge, and self-efficacy as correlates of osteoporosis preventive behaviors among preadolescent females. J Pediatr Psychol 2003; 28:335-45
29. Kalkwarf HJ, Khoury JC, Lanphear BP: Milk intake during childhood and adolescence, adult bone density, and osteoporotic fractures in US women. Am J Clin Nutr 2003; 77:257-65
30. Looker AC: Interaction of science, consumer practices and policy: Calcium and bone health as a case study. J Nutr 2003; 133:19878-19918
31. Yoshimura N: [Exercise and physical activities for the prevention of osteoporotic fractures: a review of the evidence]. Nippon Eiseigaku Zasshi 2003; 58:328-37
32. Aquila R, Emanuel M: Interventions for weight gain in adults treated with novel antipsychotics. Prim Care Companion J Clin Psychiatry 2000; 2:20-23
33. Ball MP, Coons VB, Buchanan RW: A program for treating olanzapine-related weight gain. Psychiatr Serv 2001; 52:967-9
34. Umbricht D, Flury H, Bridler R: Cognitive behavior therapy for weight gain. Am J Psychiatry 2001; 158:971
35. Goff DC, Henderson DC, Amico E: Cigarette smoking in schizophrenia: Relationship to psychopathology and medication side effects. Am J Psychiatry 1992; 149:1189-94
36. Shimoda K, Someya T, Morita S, et al.: Lower plasma levels of haloperidol in smoking than in nonsmoking schizophrenic patients. Ther Drug Monit 1999; 21:293-6
37. Stimmel GL, Falloon IR: Chlorpromazine plasma levels, adverse effects, and tobacco smoking: Case report. J Clin Psychiatry 1983; 44:420-2
38. Calle EE, Thun MJ, Petrelli JM, et al.: Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341:1097-105
39. Manson JE, Colditz GA, Stampfer MJ, et al.: A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990; 322:882-9
40. U.S. Department of Health and Human Services and U.S. Department of Agriculture. Dietary Guidelines for Americans, 2005. 6th Edition, Washington, D.C.: U.S. Government Printing Office, January 2005.